Search - tctmd.com

Displaying 901 - 920 of 2472

Sort: Relevancy | Date

Presentation TCT 2015

KEYNOTE LECTURE: Redefining Aortic Stenosis Use of Advanced Imaging, Hemodynamics, Computational Models, and Clinical Data to Revise Trigger Points for Treatment

Presenter: Eberhard Grube, Michael J. Mack, Elazer R. Edelman

October 11, 2015

Presentation TCT 2015

The New MVARC Consensus Documents: Take-home Messages

Presenter: Patrick T. O'Gara, Allan Schwartz, Gregg W. Stone

October 11, 2015

Presentation TCT 2015

The Mitral Valve Heart Team: How to Make This More Than a Concept

Presenter: Patrick T. O'Gara, Allan Schwartz, David L. Brown

October 11, 2015

Presentation TCT 2015

Which Patients for TAVR? Will Surgical Risk Stratification Remain the Dominant Strategy in the Future?

Presenter: Eberhard Grube, Michael J. Mack, John G. Webb

October 11, 2015

Presentation TCT 2015

Whats Controversial or Unsettled in the Guidelines?

Presenter: Patrick T. O'Gara, Allan Schwartz, Robert O. Bonow

October 11, 2015

Presentation TCT 2015

Whats New in the Guidelines?

Presenter: Patrick T. O'Gara, Allan Schwartz, Catherine M. Otto

October 11, 2015

Presentation TCT 2015

Debate: Fate of the Multidisciplinary Heart Valve Team as TAVR Becomes a TF-First Minimalist Procedure Inevitable Decline!

Presenter: Eberhard Grube, Michael J. Mack, Ganesh Manoharan

October 11, 2015

Presentation TCT 2015

Debate: Fate of the Multidisciplinary Heart Valve Team as TAVR Becomes a TF-First Minimalist Procedure That Would Be a Mistake!

Presenter: Eberhard Grube, Michael J. Mack, A. Pieter Kappetein

October 11, 2015

Presentation TCT 2015

How Effective Is CRT in Reducing MR?

Presenter: Patrick T. O'Gara, Allan Schwartz, William T. Abraham

October 11, 2015

Presentation TCT 2015

Medical Therapy for Mitral Regurgitation: Does Anything Work?

Presenter: Patrick T. O'Gara, Allan Schwartz

October 11, 2015

Presentation TCT 2015

Epidemiology and Treatment of Mitral Valvular Regurgitation: What We Don't Know That We Should!

Presenter: Patrick T. O'Gara, Allan Schwartz, Alec S. Vahanian

October 11, 2015

Presentation TCT 2015

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Noninvasive Cardiologists Perspective

Presenter: Eberhard Grube, Michael J. Mack, Robert O. Bonow

October 11, 2015

Presentation TCT 2015

The Current Epidemiology and Treatment of Mitral Valvular Regurgitation in the US and EU

Presenter: Patrick T. O'Gara, Allan Schwartz, Jeffrey S. Borer

October 11, 2015

Presentation TCT 2015

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Cardiac Surgeons Perspective

Presenter: Eberhard Grube, Michael J. Mack

October 11, 2015

Presentation TCT 2015

A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists

Presenter: Patrick T. O'Gara, Allan Schwartz, Mark Reisman

October 11, 2015

Presentation TCT 2015

TAVR is a Breakthrough Technology: Important Milestones and Emerging Controversies

Presenter: Eberhard Grube, Michael J. Mack, Raj Makkar

October 11, 2015

Presentation TCT 2015

Introduction

Presenter: Eberhard Grube, Michael J. Mack, Martin B. Leon

October 11, 2015

Presentation TCT 2015

A Pathologic Understanding of the Mitral Valve Complex

Presenter: Patrick T. O'Gara, Allan Schwartz, Renu Virmani

October 11, 2015

Presentation TCT 2015

MitraClip Case Presentation

Presenter: Sarah Clarke, Anita Asgar

October 11, 2015

Presentation TCT 2015

Current TMVR Landscape: MitraClip and Beyond

Presenter: Sarah Clarke, Joachim Schofer

October 11, 2015

Advertisement

KEYNOTE LECTURE: Redefining Aortic Stenosis Use of Advanced Imaging, Hemodynamics, Computational Models, and Clinical Data to Revise Trigger Points for Treatment

The New MVARC Consensus Documents: Take-home Messages

The Mitral Valve Heart Team: How to Make This More Than a Concept

Which Patients for TAVR? Will Surgical Risk Stratification Remain the Dominant Strategy in the Future?

Whats Controversial or Unsettled in the Guidelines?

Whats New in the Guidelines?

Debate: Fate of the Multidisciplinary Heart Valve Team as TAVR Becomes a TF-First Minimalist Procedure Inevitable Decline!

Debate: Fate of the Multidisciplinary Heart Valve Team as TAVR Becomes a TF-First Minimalist Procedure That Would Be a Mistake!

How Effective Is CRT in Reducing MR?

Medical Therapy for Mitral Regurgitation: Does Anything Work?

Epidemiology and Treatment of Mitral Valvular Regurgitation: What We Don't Know That We Should!

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Noninvasive Cardiologists Perspective

The Current Epidemiology and Treatment of Mitral Valvular Regurgitation in the US and EU

Pioneers Corner: Reflections on the Impact of TAVR on Aortic Valve Therapy (Now and in the Future) The Cardiac Surgeons Perspective

A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists

TAVR is a Breakthrough Technology: Important Milestones and Emerging Controversies

Introduction

A Pathologic Understanding of the Mitral Valve Complex

MitraClip Case Presentation

Current TMVR Landscape: MitraClip and Beyond

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content